Espoo
Finland
84
2026-04-28
74
2026-04-28
These are the the leading inventors for applications assigned to ORION CORPORATION:
ORION CORPORATION based in Espoo, FI has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Pharmaceutical composition of darolutamide
#2 | 2024-05-30PROCESS FOR THE PREPARATION OF A CYP11A1 INHIBITOR AND INTERMEDIATES THEREOF
#3 | 2024-05-16SOLID FORMS OF A 4H-PYRAN-4-ONE STRUCTURED CYP11A1 INHIBITOR
#4 | 2024-05-16NOVEL SALT FORMS OF A 4H-PYRAN-4-ONE STRUCTURED CYP11A1 INHIBITOR
#5 | 2024-02-15 ✅ Patent 12,521,363 granted on 2026-01-13USE OF LEVODOPA, CARBIDOPA AND ENTACAPONE FOR TREATING PARKINSON'S DISEASE
#6 | 2023-06-08 ✅ Patent 12,583,840 granted on 2026-03-24METHOD FOR THE PREPARATION OF ANDROGEN RECEPTOR ANTAGONISTS AND INTERMEDIATES THEREOF
#7 | 2022-11-17 ✅ Patent 12,329,742 granted on 2025-06-17PHARMACEUTICAL COMPOSITION OF DAROLUTAMIDE
#8 | 2022-06-09 ✅ Patent 12,558,331 granted on 2026-02-24PREGABALIN FORMULATIONS AND USE THEREOF
#9 | 2021-11-11 ✅ Patent 12,030,871 granted on 2024-07-09Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors
#10 | 2021-05-13 ✅ Patent 11,332,460 granted on 2022-05-17Process for the preparation of a sulfonamide structured kinase inhibitor
#11 | 2021-03-25 ✅ Patent 11,771,675 granted on 2023-10-03Use of levodopa, carbidopa and entacapone for treating Parkinson's disease
#12 | 2020-11-05 ✅ Patent 11,433,021 granted on 2022-09-06Palonosetron for the treatment or prevention of nausea and vomiting
#13 | 2020-10-01 ✅ Patent 11,352,346 granted on 2022-06-07Process for the preparation of 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1H-imidazole and the hydrogensulfate salt thereof
#14 | 2020-09-24 ✅ Patent 11,046,713 granted on 2021-06-29Androgen receptor modulating compounds
#15 | 2020-09-24 ✅ Patent 11,098,032 granted on 2021-08-24Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors
#16 | 2020-04-02 ✅ Patent 10,870,637 granted on 2020-12-22Process for the preparation of a sulfonamide structured kinase inhibitor
#17 | 2020-02-06 ✅ Patent 11,168,058 granted on 2021-11-09Manufacture of a crystalline pharmaceutical product
#18 | 2019-11-28 ✅ Patent 10,717,726 granted on 2020-07-21Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors
#19 | 2019-10-24 ✅ Patent 10,835,515 granted on 2020-11-17Carboxamide derivative and its diastereomers in stable crystalline form
#20 | 2019-09-262-(1-HETEROARYLPIPERAZIN-4-YL)METHYL-1,4-BENZODIOXANE DERIVATIVES AS ALPHA2C ANTAGONISTS
#21 | 2019-04-04 ✅ Patent 10,711,013 granted on 2020-07-14Androgen receptor modulating compounds
#22 | 2018-11-29 ✅ Patent 10,590,118 granted on 2020-03-17Bicyclic heterocyclic derivatives as bromodomain inhibitors
#23 | 2018-10-04 ✅ Patent 10,376,494 granted on 2019-08-13Carboxamide derivative and its diastereomers in stable crystalline form
#24 | 2018-10-04 ✅ Patent 10,383,853 granted on 2019-08-20Carboxamide derivative and its diastereomers in stable crystalline form
#25 | 2018-09-06 ✅ Patent 10,391,082 granted on 2019-08-27Protein kinase inhibitors
#26 | 2018-08-02 ✅ Patent 10,774,074 granted on 2020-09-152-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane derivatives as alpha2C antagonists
#27 | 2018-04-12 ✅ Patent 10,189,789 granted on 2019-01-29Process for the preparation of androgen receptor antagonists and intermediates thereof
#28 | 2017-09-14 ✅ Patent 10,118,933 granted on 2018-11-06Androgen receptor modulating compounds
#29 | 2017-08-17 ✅ Patent 10,357,492 granted on 2019-07-23Levosimendan for use in the treatment of motor neuron diseases (E.G. ALS)
#30 | 2016-12-22 ✅ Patent 10,077,259 granted on 2018-09-18Bicyclic heterocyclic derivatives as bromodomain inhibitors
#31 | 2016-07-21 ✅ Patent 10,092,510 granted on 2018-10-09Veterinary method for inducing emesis
#32 | 2016-02-04PROTEIN KINASE INHIBITORS
#33 | 2015-12-31 ✅ Patent 9,533,952 granted on 2017-01-03N-prop-2-ynyl carboxamide derivatives and their use as TRPA1 antagonists
#34 | 2015-09-17 ✅ Patent 10,780,079 granted on 2020-09-22Veterinary method of alleviating noise aversion
#35 | 2015-08-06 ✅ Patent 9,458,128 granted on 2016-10-04Catechol O-methyltransferase activity inhibiting compounds
#36 | 2015-06-04 ✅ Patent 10,857,120 granted on 2020-12-08Use of levodopa, carbidopa and entacapone for treating Parkinson's disease
#37 | 2015-03-05 ✅ Patent 9,249,127 granted on 2016-02-02Alpha2 adrenoceptor agonists
#38 | 2015-01-08 ✅ Patent 9,447,091 granted on 2016-09-20Protein kinase inhibitors
#39 | 2014-07-17PROTEASE INHIBITORS
#40 | 2014-06-26 ✅ Patent 8,809,536 granted on 2014-08-192,3-dihydrobenzo[1,4] dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases
#41 | 2014-04-10 ✅ Patent 9,078,883 granted on 2015-07-14Treatment or prevention of hypotension and shock
#42 | 2014-04-03 ✅ Patent 8,921,378 granted on 2014-12-30Androgen receptor modulating carboxamides
#43 | 2013-10-24 ✅ Patent 8,697,723 granted on 2014-04-152,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases
#44 | 2013-05-30USE OF LEVODOPA, CARBIDOPA AND ENTACAPONE FOR TREATING PARKINSON'S DISEASE
#45 | 2012-11-15ORAL DOSAGE FORM
#46 | 2012-09-06 ✅ Patent 8,975,254 granted on 2015-03-10Androgen receptor modulating compounds
#47 | 2012-05-31 ✅ Patent 8,722,930 granted on 2014-05-13Protease inhibitors
#48 | 2011-12-08 ✅ Patent 8,329,693 granted on 2012-12-11Method for the prevention of thromboembolic disorders
#49 | 2011-04-14 ✅ Patent 8,318,785 granted on 2012-11-27Pharmaceutical compounds
#50 | 2011-03-24 ✅ Patent 8,309,591 granted on 2012-11-13Transmucosal veterinary composition comprising detomidine
#51 | 2010-08-26 ✅ Patent 8,492,549 granted on 2013-07-232,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous systeme diseases
#52 | 2009-02-26 ✅ Patent 8,501,814 granted on 2013-08-06Selective androgen receptor modulators
#53 | 2009-02-03 ✅ Patent 7,485,642 granted on 2009-02-03Method for treating septic shock
#54 | 2009-01-08 ✅ Patent 7,932,415 granted on 2011-04-26Process for manufacturing entacapone
#55 | 2008-11-20 ✅ Patent 7,728,147 granted on 2010-06-01Detomidine hydrochloride crystallization method
#56 | 2008-11-06 ✅ Patent 7,642,279 granted on 2010-01-05Atipamezole hydrochloride crystallization method
#57 | 2008-10-30Prolyl Oligopeptidase Inhibitors Ameliorating Recovery From Brain Trauma
#58 | 2008-09-16 ✅ Patent 7,425,568 granted on 2008-09-16Compounds, which are potent inhibitors of Na /Ca exchange mechanism and are useful in the treatment of arrhythmias
#59 | 2008-08-28Treatment of Epilepsy
#60 | 2008-02-14 ✅ Patent 8,017,609 granted on 2011-09-13Method for the prevention of thromboembolic disorders
#61 | 2007-12-27 ✅ Patent 7,863,311 granted on 2011-01-04Transmucosal veterinary composition comprising detomidine
#62 | 2007-09-11 ✅ Patent 7,267,813 granted on 2007-09-11Inhalation particles incorporating a combination of two or more active ingredients
#63 | 2007-05-31 ✅ Patent 7,390,923 granted on 2008-06-24Propionamide derivatives useful as androgen receptor modulators
#64 | 2007-04-26 ✅ Patent 7,368,607 granted on 2008-05-06Toremifene crystallization method
#65 | 2007-02-06 ✅ Patent 7,172,752 granted on 2007-02-06Combination particles for the treatment of asthma
#66 | 2006-10-26 ✅ Patent 7,482,340 granted on 2009-01-27Pyridine derivatives useful for inhibiting sodium/calcium exchange system
#67 | 2006-10-03 ✅ Patent 7,115,604 granted on 2006-10-03Method for treating erectile dysfunction
#68 | 2006-08-10 ✅ Patent 7,759,496 granted on 2010-07-20Imidazole derivatives having affinity for alpha 2 receptors activity
#69 | 2006-05-16 ✅ Patent 7,045,147 granted on 2006-05-16Controlled release peroral compositions of levosimendan
#70 | 2006-05-04 ✅ Patent 7,592,350 granted on 2009-09-22Polycyclic compounds as potent alpha2-adrenoceptor antagonists
#71 | 2006-01-10 ✅ Patent 6,983,748 granted on 2006-01-10Dry powder inhaler
#72 | 2005-10-04 ✅ Patent 6,951,870 granted on 2005-10-04Coumarin derivatives with COMT inhibiting activity
#73 | 2005-09-27 ✅ Patent 6,949,548 granted on 2005-09-27Combination therapy for the treatment of heart failure
#74 | 2005-09-27 ✅ Patent 6,948,495 granted on 2005-09-27Powder inhaler
#75 | 2005-09-13 ✅ Patent 6,943,164 granted on 2005-09-13Pharmaceutical solutions of levosimendan
#76 | 2005-08-09 ✅ Patent 6,926,003 granted on 2005-08-09Multidose powder inhaler
#77 | 2005-06-28 ✅ Patent 6,911,209 granted on 2005-06-28Method of treating sick sinus syndrome with levosimendan
#78 | 2005-06-07 ✅ Patent 6,903,114 granted on 2005-06-07Derivatives of naphthalene with COMT inhibiting activity
#79 | 2005-05-03 ✅ Patent 6,887,888 granted on 2005-05-03Soluble compositions of triphenylethylene antiestrogens
#80 | 2005-05-03 ✅ Patent 6,886,560 granted on 2005-05-03Moisture protected powder inhaler
#81 | 2005-04-12 ✅ Patent 6,878,702 granted on 2005-04-12Anti-inflammatory agents
#82 | 2005-01-27 ✅ Patent 7,173,024 granted on 2007-02-06Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use
#83 | 2005-01-25 ✅ Patent 6,846,496 granted on 2005-01-25Treatment of osteoporosis
#84 | 2005-01-13 ✅ Patent 8,550,070 granted on 2013-10-08Powder inhaler
Also check out ORION CORPORATION's (Espoo, Finland) applicant profile with 56 patent applications submitted.
60438 ⎘